Headline News about Takeda Pharmaceutical Ltd ADR
Looking Into Takeda Pharmaceutical's Recent Short Interest
September 25, 2023
Via Benzinga
Via Benzinga
Ovarian Cancer Player ImmunoGen Can Potentially Be Attractive M&A Target: JP Morgan
September 13, 2023
Via Benzinga
(TAK) - Analyzing Takeda Pharmaceutical's Short Interest
September 08, 2023
Via Benzinga
Via The Motley Fool
How Is The Market Feeling About Takeda Pharmaceutical?
August 17, 2023
Via Benzinga
(TAK) - Analyzing Takeda Pharmaceutical's Short Interest
August 01, 2023
Via Benzinga
(TAK) - Analyzing Takeda Pharmaceutical's Short Interest
July 14, 2023
Via Benzinga
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|